Date: 2025/04/26 - 00:00
The FDA issued a warning about adverse effects related to a popular hair loss product available through telehealth platforms like Hims & Hers and Ro. Men have reported side effects of topical finasteride, including depression, dizziness, and low libido.
Date: 2025/04/25 - 23:00
The FDA issued a warning about adverse effects related to a popular hair loss product available through telehealth platforms like Hims & Hers and Ro. Men have reported side effects of topical finasteride, including depression, dizziness, and low libido.
Date: 2025/04/02 - 23:32
The FDA's new rule restricting the sale of compounded semaglutide could make it more difficult for some people to obtain affordable weight loss medications. Here, two people who've relied on compounded GLP-1 drugs share their stories.
Date: 2025/04/02 - 23:00
The FDA's new rule restricting the sale of compounded semaglutide could make it more difficult for some people to obtain affordable weight loss medications. Here, two people who've relied on compounded GLP-1 drugs share their stories.
Date: 2025/03/20 - 00:00
The FDA ordered compounding pharmacies to stop making copycat versions of weight loss drugs like Ozempic and Zepbound now that the GLP-1 drug shortage has ended. People who rely on compounded GLP-1s say they may not be able to afford brand-name versions, which are often not covered by insurance.
Date: 2025/03/17 - 15:01
People without diabetes can lose up to 13% of their starting weight in 6 months using tirzepatide (Mounjaro) as an off-label treatment, according to a new study funded by pharmaceutical company Eli Lilly.
Date: 2025/03/14 - 23:32
Spring allergy season is expected to worsen in 2025. Longer growing seasons due to climate change have caused seasonal allergies to become more severe. You can limit pollen exposure during allergy season with frequent handwashing and limiting time spent outdoors when pollen levels are high.